Questionable value of [99mTc]-sestamibi scintigraphy in patients with pHPT and negative ultrasound
- PMID: 35945299
- PMCID: PMC9722861
- DOI: 10.1007/s00423-022-02648-9
Questionable value of [99mTc]-sestamibi scintigraphy in patients with pHPT and negative ultrasound
Abstract
Purpose: A successful focused surgical approach in primary hyperparathyroidism (pHPT) relies on accurate preoperative localization of the parathyroid adenoma (PA). Most often, ultrasound is followed by [99mTc]-sestamibi scintigraphy, but the value of this approach is disputed. Here, we evaluated the diagnostic approach in patients with surgically treated pHPT in our center with the aim to further refine preoperative diagnostic procedures.
Methods: A single-center retrospective analysis of patients with pHPT from 01/2005 to 08/2021 was carried out followed by evaluation of the preoperative imaging modalities to localize PA. The localization of the PA had to be confirmed intraoperatively by the fresh frozen section and significant dropping of the intraoperative parathyroid hormone (PTH) levels.
Results: From 658 patients diagnosed with pHPT, 30 patients were excluded from the analysis because of surgery for recurrent or persistent disease. Median age of patients was 58.0 (13-93) years and 71% were female. Neck ultrasound was carried out in 91.7% and localized a PA in 76.6%. In 23.4% (135/576) of the patients, preoperative neck ultrasound did not detect a PA. In this group, [99mTc]-sestamibi correctly identified PA in only 25.4% of patients. In contrast, in the same cohort, the use of [11C]-methionine or [11C]-choline PET resulted in the correct identification of PA in 79.4% of patients (OR 13.23; 95% CI 5.24-33.56).
Conclusion: [11C]-Methionine or [11C]-choline PET/CT are superior second-line imaging methods to select patients for a focused surgical approach when previous ultrasound failed to identify PA.
Keywords: Focused surgical approach; Parathyroid adenoma; Primary hyperparathyroidism; [11C]-Choline PET/CT; [11C]-Methionine; [99mTc]-Sestamibi scan.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.J Clin Endocrinol Metab. 2014 Nov;99(11):4199-205. doi: 10.1210/jc.2014-1267. Epub 2014 Jul 16. J Clin Endocrinol Metab. 2014. PMID: 25029418
-
Role of 99mTc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery.Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1091-4. doi: 10.1007/s00259-006-0162-y. Epub 2006 Jun 28. Eur J Nucl Med Mol Imaging. 2006. PMID: 16804688 Clinical Trial.
-
Redefining preoperative imaging-based localization of adenomas in primary hyperparathyroidism patients candidates for minimally invasive surgery.Rev Esp Med Nucl Imagen Mol (Engl Ed). 2025 Jul-Aug;44(4):500091. doi: 10.1016/j.remnie.2025.500091. Epub 2025 Feb 5. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2025. PMID: 39921169
-
Diagnostic utility of 11 C-methionine PET/CT in primary hyperparathyroidism in a UK cohort: A single-centre experience and literature review.Clin Endocrinol (Oxf). 2023 Sep;99(3):233-245. doi: 10.1111/cen.14933. Epub 2023 Jun 5. Clin Endocrinol (Oxf). 2023. PMID: 37272391 Review.
-
Contemporary localization diagnostics in primary hyperparathyroidism. Review of visualization techniques including ultrasonography, PTH washout, 99mTc-MIBI scintigraphy, and 18F-choline PET.Endokrynol Pol. 2025;76(2):127-133. doi: 10.5603/ep.103003. Endokrynol Pol. 2025. PMID: 40331843 Review.
Cited by
-
[Current approach in cases of persistence and recurrence of primary hyperparathyroidism].Chirurgie (Heidelb). 2023 Jul;94(7):595-601. doi: 10.1007/s00104-023-01852-7. Epub 2023 May 26. Chirurgie (Heidelb). 2023. PMID: 37233782 Review. German.
-
The Use of [11C]C-Methionine in Diagnostics of Endocrine Disorders with Focus on Pituitary and Parathyroid Glands.Pharmaceuticals (Basel). 2025 Feb 7;18(2):229. doi: 10.3390/ph18020229. Pharmaceuticals (Basel). 2025. PMID: 40006042 Free PMC article. Review.
-
[Parathyroid glands and their anatomical positional variations : Preoperative diagnostics and surgical planning].Chirurgie (Heidelb). 2025 Jul 24. doi: 10.1007/s00104-025-02343-7. Online ahead of print. Chirurgie (Heidelb). 2025. PMID: 40705067 Review. German.
-
68Ga-Trivehexin PET/CT: a promising novel tracer for primary hyperparathyroidism.Eur J Nucl Med Mol Imaging. 2024 Nov;51(13):3912-3923. doi: 10.1007/s00259-024-06846-z. Epub 2024 Jul 19. Eur J Nucl Med Mol Imaging. 2024. PMID: 39028425 Free PMC article.
-
The Utility of 4D-CT Imaging in Primary Hyperparathyroidism Management in a Low-Volume Center.Medicina (Kaunas). 2023 Aug 3;59(8):1415. doi: 10.3390/medicina59081415. Medicina (Kaunas). 2023. PMID: 37629704 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources